menu
    • menu

    Company profile for BioCity Biopharma

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BioCity was established in December 2017. It is an innovative drug company created by local entrepreneurs who have a deep understanding of the Chinese pharmaceutical market and young returned scientists relying on the world's leading open drug innovation platform. The company is committed to the discovery, development, and commercialization of novel or highly differentiated candidates (with no modality limitation) to treat dis...
    BioCity was established in December 2017. It is an innovative drug company created by local entrepreneurs who have a deep understanding of the Chinese pharmaceutical market and young returned scientists relying on the world's leading open drug innovation platform. The company is committed to the discovery, development, and commercialization of novel or highly differentiated candidates (with no modality limitation) to treat diseases with significant unmet medical needs, particularly cancers, and Nephropathy.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BioCity BiopharmaChina Flag
    Country
    Country
    China
    Address
    Address
    HuiChuang Building West Wing 24th Floor , Jianzhu West Road No.581,Binhu Distr...
    Telephone
    Telephone
    +86 0510-88856588
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.biocitypharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BioCity’s SC0062 Gets Breakthrough Tag for Diabetic Kidney Dx
    BioCity’s SC0062 Gets Breakthrough Tag for Diabetic Kidney Dx

    25 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biocitys-eta-selective-antagonist-sc0062-granted-breakthrough-therapy-designation-in-china-for-diabetic-kidney-disease-with-albuminuria-302491559.html

    PR NEWSWIRE
    25 Jun 2025
    Share Share
    BioCity, MSD Partner To Evaluate BC3195 + Keytruda In Solid Tumors
    BioCity, MSD Partner To Evaluate BC3195 + Keytruda In Solid Tumors

    13 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biocity-biopharmaceutics-co-ltd-announces-clinical-collaboration-to-evaluate-bc3195-in-combination-with-keytruda-pembrolizumab-in-patients-with-locally-advanced-or-metastatic-solid-tumors-302400770.html

    PR NEWSWIRE
    13 Mar 2025
    Share Share
    BioCity’s ETA antagonist reduces proteinuria in ph. 2 DKD trial
    BioCity’s ETA antagonist reduces proteinuria in ph. 2 DKD trial

    25 Feb 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/biocitys-eta-antagonist-reduces-proteinuria-phase-2-trial-diabetic-kidney-disease

    FIERCE BIOTECH
    25 Feb 2025
    Share Share
    BioCity's SC0062 Met Primary Endpoint in DKD Phase 2 Trial
    BioCity's SC0062 Met Primary Endpoint in DKD Phase 2 Trial

    25 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biocity-announces-its-selective-endothelin-type-a-receptor-antagonist-sc0062-met-the-primary-endpoint-in-diabetic-kidney-disease-dkd-in-a-phase-2-trial-2-succeed-302384313.html

    PR NEWSWIRE
    25 Feb 2025
    Share Share
    BioCity To Present SC0062 Data At ASN 2024 And In JASN
    BioCity To Present SC0062 Data At ASN 2024 And In JASN

    14 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biocity-will-present-the-late-breaking-clinical-trial-data-of-its-eta-selective-antagonist-sc0062-at-the-american-society-of-nephrology-asn-2024-with-simultaneous-publication-of-the-trial-data-in-the-journal-of-the-american-soci-302274975.html

    PR NEWSWIRE
    14 Oct 2024
    Share Share
    BioCity's Granted BTD By NMPA For IgA Nephropathy with Proteinuria
    BioCity's Granted BTD By NMPA For IgA Nephropathy with Proteinuria

    26 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/breakthrough-therapy-designation-btd-for-biocitys-sc0062-a-selective-endothelin-type-a-eta-antagonist-granted-by-national-medical-products-administration-for-iga-nephropathy-igan-with-proteinuria-302259663.html

    PR NEWSWIRE
    26 Sep 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search